Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Büller

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|April 16, 1999
Assessment of quality of life in the younger child: the use of an animated computer programH Büller
Haemostasis|January 12, 2000
Is there a role for thrombolytic therapy in venous thromboembolism?B J Sanson, H Büller
Journal of Thrombosis and Haemostasis : JTH|September 17, 2011
External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?J Beyer-Westendorf, H Büller
European Journal of Pediatrics|December 1, 1986
Vitamin-K status beyond the neonatal period. A prospective study in normal breast-fed and formula-fed infantsH Büller, M Peters, B Burger, et al.
Journal of Thrombosis and Haemostasis : JTH|February 3, 2011
Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trialP Verhamme, M Tangelder, R Verhaeghe, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolismJ D Douketis, O Leeuwenkamp, P Grobara, et al.
Vascular|January 25, 2012
Treatment for intermittent claudication and the effects on walking distance and quality of lifeL M Kruidenier, W Viechtbauer, S P Nicolaï, et al.
Journal of Thrombosis and Haemostasis : JTH|April 12, 2013
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trialsG Raskob, H Büller, M Prins, et al.
Journal of the American College of Cardiology|October 1, 1993
Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis GroupM Verstraete, M Nurmohamed, J Kienast, et al.
Lancet (London, England)|June 18, 1994
Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor VJ Voorberg, J Roelse, R Koopman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Pediatric Gastroenterology and Nutrition|April 16, 1999
Assessment of quality of life in the younger child: the use of an animated computer programH Büller
Haemostasis|January 12, 2000
Is there a role for thrombolytic therapy in venous thromboembolism?B J Sanson, H Büller
Journal of Thrombosis and Haemostasis : JTH|September 17, 2011
External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?J Beyer-Westendorf, H Büller
European Journal of Pediatrics|December 1, 1986
Vitamin-K status beyond the neonatal period. A prospective study in normal breast-fed and formula-fed infantsH Büller, M Peters, B Burger, et al.
Journal of Thrombosis and Haemostasis : JTH|February 3, 2011
Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trialP Verhamme, M Tangelder, R Verhaeghe, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolismJ D Douketis, O Leeuwenkamp, P Grobara, et al.
Vascular|January 25, 2012
Treatment for intermittent claudication and the effects on walking distance and quality of lifeL M Kruidenier, W Viechtbauer, S P Nicolaï, et al.
Journal of Thrombosis and Haemostasis : JTH|April 12, 2013
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trialsG Raskob, H Büller, M Prins, et al.
Journal of the American College of Cardiology|October 1, 1993
Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis GroupM Verstraete, M Nurmohamed, J Kienast, et al.
Lancet (London, England)|June 18, 1994
Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor VJ Voorberg, J Roelse, R Koopman, et al.
Pageof 2